Guidance for peptide vaccines for the treatment of cancer

Author:

Yamaguchi Yoshiyuki1,Yamaue Hiroki2,Okusaka Takuji3,Okuno Kiyotaka4,Suzuki Hiroyuki5,Fujioka Tomoaki6,Otsu Atsushi7,Ohashi Yasuo8,Shimazawa Rumiko9,Nishio Kazuto10,Furuse Junji11,Minami Hironobu12,Tsunoda Takuya13,Hayashi Yuzo14,Nakamura Yusuke15,

Affiliation:

1. Department of Clinical Oncology Kawasaki Medical School KurashikiJapan

2. Second Department of Surgery Wakayama Medical University WakayamaJapan

3. Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital TokyoJapan

4. Department of Surgery Kinki University Faculty of Medicine OsakaJapan

5. Department of Regenerative Surgery Fukushima Medical University FukushimaJapan

6. Department of Urology Iwate Medical University MoriokaJapan

7. National Cancer Center Hospital East KashiwaJapan

8. Department of Biostatistics School of Public Health The University of Tokyo TokyoJapan

9. Pharmaceutical Sciences Nagasaki University Graduate School of Biomedical Sciences NagasakiJapan

10. Department of Genome Biology Kinki University Faculty of Medicine OsakaJapan

11. Department of Medical Oncology Kyorin University School of Medicine MitakaJapan

12. Department Medical Oncology/Hematology Kobe University KobeJapan

13. OncoTherapy Science Kawasaki

14. Central Institute for Experimental Animals Tokyo Japan

15. The University of Chicago Chicago Illinois, USA

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3